about
Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cellsTargeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon GammaSimultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesionsNew Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleMolecular Cues Guiding Matrix Stiffness in Liver FibrosisNoninvasive Measures of Liver Fibrosis and Severity of Liver Disease.Loss of pericyte smoothened activity in mice with genetic deficiency of leptin.Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients.Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis.Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularizationMatrix Metalloproteinase Mediated Type I Collagen Degradation - An Independent Risk Factor for Mortality in Women.HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathwayEstablishment and characterization of an immortalized rat hepatic stellate cell line.TGF-β1 Induces the Dual Regulation of Hepatic Progenitor Cells with Both Anti- and Proliver Fibrosis.Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration.SP1 and UTE1 Decoy ODNs inhibit activation and proliferation of hepatic stellate cells by targeting tissue inhibitors of metalloproteinase 1.Hydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression.Proposed therapies in primary biliary cholangitis.Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis.Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells.Adverse Outcome Pathways and Drug-Induced Liver Injury Testing.Liver Fibrosis Quantification by Magnetic Resonance Imaging.Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.Immunology in the liver--from homeostasis to disease.The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy.The rationale for targeting TGF-β in chronic liver diseases.WNT-5A regulates TGF-β-related activities in liver fibrosis.Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune CellsThe histological quantification of alpha-smooth muscle actin predicts future graft fibrosis in pediatric liver transplant recipients.The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis.Anti-fibrotic actions of relaxin.
P2860
Q26753022-2C918BE6-34D6-4228-B98E-BDED906AB666Q26779055-8CFFFE10-6985-47BF-8D2F-9BA244693520Q27334528-7EC1CAA6-4B31-43A7-B968-E2DB1B99DCA8Q28070168-3D822237-E8BB-4996-806E-43C4ADD0EAAAQ28077583-2020A1A0-BCD4-4173-BEB9-6DC1AB70B78BQ30381236-EA771F35-71D5-4C67-9005-2D4018D8F3DCQ33587672-936EF71A-D7D0-422D-AAE6-7EE18482F374Q33595236-3F9EB57C-487E-40A5-8706-AE2264D5C68CQ33671258-C4CC96D7-41C1-45E0-B7E1-C6F492705C1DQ33826344-8F3FD47A-0547-4AAD-94AF-4F17E62A310DQ33912228-F4AC8E74-385D-454D-829D-96FDA2B6387DQ35947519-8073A7C7-F349-4EEF-9962-0F7F2629F52FQ36065064-297E6A95-D992-4DB0-A7ED-BB5436D09710Q36259454-7B3E0CE3-A2B0-4E4D-B641-B92D547E9CD2Q36310780-8EF7C1D5-9824-4E11-BA72-3CEA2A2A7BAEQ36328115-35BAB3D1-B4EA-4895-9391-FB9E0D373854Q36375017-76B0E8FF-85C5-461E-8FC7-C040F22C6975Q36453859-F50FC6D8-4203-4AF1-B763-67DE64154A1AQ36551969-5BE101D7-9347-4118-8E08-0D0BBF365189Q36588292-DE8C361C-58F5-4C80-8098-958A2E8E120CQ36693626-E30E853E-3F75-4312-83C6-1F930412A369Q36842868-FE1019EC-D74C-42C3-B678-0DD2CF0ECFB5Q36890560-425583E5-BDC2-4E17-9A1C-FED0B7ABA01BQ36898564-F0B66F84-D255-4243-917D-50B6FC8F8920Q37072380-36E1BD4B-FC8D-4539-B30B-68D903C04EE7Q37578291-3140A4BA-D6BC-4A7D-8D32-3458594AC378Q37609582-A5398944-ECEB-4400-98C9-0EF41AC9DE3FQ37678954-2CE695FA-0D9E-4943-8D92-BDB2410247F8Q38539524-6C9629E4-5075-478F-983F-46B173AF9A77Q38600259-AE39A586-2018-48A5-B44F-E66F3EA7687BQ38639324-AA6FFA2D-5C01-4D4E-A3D3-4039B308DACFQ38664525-6732DB32-26DF-410E-A565-026259A2713FQ38693925-C1E8B96B-5C0C-4119-BECD-DE9F96760857Q38714006-1B8F33D4-1C23-4C37-9E86-D3609D872379Q38715538-677C7919-9BC4-40F0-AA23-0A9C506231D3Q38722769-CFC475D8-FC5B-4DF4-927F-99728BD7EE8FQ38761023-0B148D03-DEB4-4E33-BB13-A4367BBC54B7Q38806808-4E73BE68-7B0C-4E53-A335-2E61132ED5FFQ38812340-74FCF50C-ADD6-4BE2-A34E-3A01E6E83883Q38850557-C137A5C1-4389-4E11-AE4A-037C42A02F14
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hepatic fibrosis: Concept to treatment.
@en
type
label
Hepatic fibrosis: Concept to treatment.
@en
prefLabel
Hepatic fibrosis: Concept to treatment.
@en
P2093
P1476
Hepatic fibrosis: Concept to treatment.
@en
P2093
Christian Trautwein
Detlef Schuppan
Massimo Pinzani
Scott L Friedman
P304
P356
10.1016/J.JHEP.2015.02.039
P433
P577
2015-04-01T00:00:00Z